The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvest Mi (di) Regulatory News (HMI)

Share Price Information for Harvest Mi (di) (HMI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.05
Bid: 2.00
Ask: 2.10
Change: 0.05 (2.50%)
Spread: 0.10 (5.00%)
Open: 2.00
High: 2.05
Low: 2.00
Prev. Close: 2.00
HMI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appendix 3B

4 Jan 2016 09:29

RNS Number : 6931K
Harvest Minerals Limited
04 January 2016
 



Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12

 

 

Name of entity

HARVEST MINERALS LIMITED

 

ABN

12 143 303 388

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

a) Fully Paid Ordinary Shares

b) Unlisted options exp 31/05/2017 @ 8.8 pence post-consolidation (0.88 pence pre-consolidation)

c) Unlisted options exp 18/12/2020 @ 7.5 pence post-consolidation (0.75 pence pre-consolidation)

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

a) 1 for 10 consolidation of 823,491,666 pre-consolidation shares to 82,249,193 post consolidated shares

b) 1 for 10 consolidation of 130,410,000 pre-consolidation unlisted options to 13,041,000 post-consolidated unlisted options

c) 1 for 10 consolidation of 9,517,200 pre-consolidation options to 951,720 post-consolidated unlisted options

 

 

3

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

a) Fully Paid Ordinary Shares

b) Unlisted options exp 31/05/2017 @ 8.8 pence (AUD $0.19) (post consolidated basis)

c) Unlisted options exp 18/12/2020 @ 7.5 pence (AUD $0.16) (post consolidated basis).

 

The share consolidation was achieved through the conversion of 10 ordinary fully paid shares into one ordinary share and 10 unlisted options into one unlisted option as approved by shareholders at the general meeting held on 17 December 2015.

 

 

 

4

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

a) Yes

b) No - Shares issued on conversion will rank equally with all ordinary shares on issue

c) No - Shares issued on conversion will rank equally with all ordinary shares on issue

 

 

 

5

Issue price or consideration

 

N/A

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

Consolidation of capital whereby 10 existing securities will become 1 security on a post consolidation basis.

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

N/A

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

N/A

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

N/A

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

N/A

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

N/A

 

 

 

6f

Number of securities issued under an exception in rule 7.2

N/A

 

 

 

 

6g

If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

N/A

 

 

 

6h

If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

 

N/A

 

 

7

Dates of entering +securities into uncertificated holdings or despatch of certificates

4 January 2016

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the securities in section 2 if applicable)

82,249,193

Fully Paid Ordinary Shares

 

 

 

 

 

 

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the securities in section 2 if applicable)

13,041,000

 

 

 

 951,720

 

Unlisted options exp 31/05/2017 @ 8.8 pence (AUD $0.19)

 

Unlisted options exp 18/12/2020 @ 7.5 pence (AUD $0.16)

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

N/A

 

 

 

Part 2 ‑ Bonus issue or pro rata issue

11

Is security holder approval required?

N/A

12

Is the issue renounceable or non-renounceable?

N/A

13

Ratio in which the +securities will be offered

N/A

14

+Class of +securities to which the offer relates

N/A

15

+Record date to determine entitlements

N/A

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

N/A

 

17

Policy for deciding entitlements in relation to fractions

N/A

18

Names of countries in which the entity has +security holders who will not be sent new issue documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

N/A

19

Closing date for receipt of acceptances or renunciations

N/A

20

Names of any underwriters

N/A

21

Amount of any underwriting fee or commission

N/A

22

Names of any brokers to the issue

N/A

23

Fee or commission payable to the broker to the issue

N/A

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of +security holders

N/A

25

If the issue is contingent on +security holders' approval, the date of the meeting

N/A

26

Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled

N/A

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

N/A

28

Date rights trading will begin (if applicable)

N/A

 

29

Date rights trading will end (if applicable)

N/A

30

How do +security holders sell their entitlements in full through a broker?

N/A

31

How do +security holders sell part of their entitlements through a broker and accept for the balance?

N/A

32

How do +security holders dispose of their entitlements (except by sale through a broker)?

N/A

33

+Despatch date

N/A

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

34

Type of securities

(tick one)

 

(a)

Securities described in Part 1

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

 

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

37

A copy of any trust deed for the additional +securities

 

 

Entities that have ticked box 34(b)

 

38

Number of securities for which +quotation is sought

N/A

 

 

39

Class of +securities for which quotation is sought

N/A

 

 

40

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

N/A

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another security, clearly identify that other security)

N/A

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the securities in clause 38)

 

 

 

N/A

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

· There is no reason why those +securities should not be granted +quotation.

 

· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

Sign here: Jonathan Hart Date: 4 January 2016

(Company Secretary)

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSUKRNNAARRR
Date   Source Headline
2nd May 20241:45 pmRNSKP Fértil® Sales Update
10th Apr 20249:01 amRNSOccurrences of REE at the Arapuá Project
10th Apr 20249:00 amRNSQ1 2024 KP Fértil® Sales Update
15th Feb 20241:11 pmRNSFull Year 2023 KP Fértil® Sales & 2024 Guidance
23rd Oct 20237:00 amRNSQ3 2023 KP Fértil® Sales Update
21st Sep 20237:32 amRNSHalf-year Report
17th Aug 202312:30 pmRNSResult of AGM
14th Aug 20237:00 amRNSTrading Statement
17th Jul 20237:00 amRNSNotice of AGM
30th Jun 20237:00 amRNSQ2 & H1 2023 KP Fértil® Sales Update
30th Jun 20237:00 amRNSFinal Results
18th Apr 20237:00 amRNSQ1 2023 KP Fértil® Sales Update
14th Feb 20239:00 amRNSTrading Update
14th Feb 20238:55 amRNSPositive Court Ruling
26th Jan 20237:00 amRNSInvestor Presentation
24th Jan 20237:54 amRNSQ4 & Full Year 2022 Sales & 2023 Guidance
7th Dec 20222:05 pmRNSSecond Price Monitoring Extn
7th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Oct 20229:17 amRNSNew Corporate Presentation
4th Oct 20224:41 pmRNSSecond Price Monitoring Extn
4th Oct 20224:36 pmRNSPrice Monitoring Extension
30th Sep 202210:13 amRNSInvestor Presentation
29th Sep 202211:07 amRNSClarification on H1 2022 Sales Orders
29th Sep 20229:06 amRNSSecond Price Monitoring Extn
29th Sep 20229:00 amRNSPrice Monitoring Extension
29th Sep 20227:30 amRNSQ3 2022 KP Fértil® Sales Up
29th Sep 20227:01 amRNSInterim Results
7th Sep 20228:45 amRNSHolding(s) in Company
30th Aug 20228:06 amRNSResult of AGM
4th Aug 20228:28 amRNSMiriri Phosphate Project Update
28th Jul 20227:00 amRNSNotice of AGM
8th Jul 202211:00 amRNSPrice Monitoring Extension
6th Jul 202212:15 pmRNSAdmission to Trading / TVR Clarification
4th Jul 202211:38 amRNSInvestor Presentation - Change of Time
1st Jul 202210:42 amRNSInvestor Presentation
30th Jun 20227:00 amRNSSales Update
30th Jun 20227:00 amRNSFinal Results
30th Mar 20224:41 pmRNSSecond Price Monitoring Extn
30th Mar 20224:35 pmRNSPrice Monitoring Extension
30th Mar 20222:05 pmRNSSecond Price Monitoring Extn
30th Mar 20222:00 pmRNSPrice Monitoring Extension
30th Mar 202211:06 amRNSSecond Price Monitoring Extn
30th Mar 202211:01 amRNSPrice Monitoring Extension
30th Mar 20227:14 amRNSFirst Quarter 2022 KP Fértil® Sales Performance
29th Mar 20224:40 pmRNSSecond Price Monitoring Extn
29th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Mar 20222:06 pmRNSSecond Price Monitoring Extn
28th Mar 20222:01 pmRNSPrice Monitoring Extension
8th Mar 202211:05 amRNSSecond Price Monitoring Extn
8th Mar 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.